Publications by authors named "C Danel"

Claim this Profile
H
Hospital production of a 1% propofol-cyclodextrin formulation to address drug shortages: a proof of concept.
Damien Rousseleau, Myriam Bouchfaa, Laura Négrier, Marine Roche, Nathalie Azaroual, Cécile Danel

Eur J Hosp Pharm· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-193b-3p and miR-132-3p as prognostic biomarkers of survival in pleural mesothelioma patients treated with first-line bevacizumab plus pemetrexed-platinum chemotherapy in the IFCT-0701 MAPS phase 3 trial.
Guénaëlle Levallet, Christian Creveuil, Alexandre Léger-Vigot, Solenn Brosseau, Claire Danel

Transl Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of a propofol emulsion with alpha-2 adrenergic receptor agonists used for multimodal analgesia or sedation in intensive care units: a physicochemical stability study.
Marine Roche, Damien Rousseleau, Cécile Danel, Héloïse Henry, Gilles Lebuffe

Eur J Hosp Pharm· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physicochemical stability of a polysorbate-80-containing solvent compounded in the hospital pharmacy and used to reconstitute a biologic for nebulisation.
Laura Négrier, Marine Roche, Damien Lannoy, Christophe Berneron, Léa Pacqueu, Cécile Danel

Eur J Hosp Pharm· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial).
Karine Lacombe, Raoul Moh, Corine Chazallon, Maud Lemoine, Babacar Sylla, Christine Danel

Sci Rep· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis